ArticleNature reviews. Drug discovery2011
US academic drug discovery.
Article in Nature reviews. Drug discovery, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- From Lab to Clinic: Effect of Academia-Industry Collaboration Characteristics on Oncology Phase 1 Trial Entry.Clinical and translational science · 2025Article
- Precision cardiovascular medicine: shifting the innovation paradigm.Frontiers in science · 2025Article
- HighVia-A Flexible Live-Cell High-Content Screening Pipeline to Assess Cellular Toxicity.SLAS discovery : advancing life sciences R & D · 2020Article
- Surviving in the Valley of Death: Opportunities and Challenges in Translating Academic Drug Discoveries.Annual review of pharmacology and toxicology · 2019Review
- The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development.Clinical and translational science · 2018Article
- Academic Drug Development: The DRIVE Model.ACS medicinal chemistry letters · 2018Article
- Chemotext: A Publicly Available Web Server for Mining Drug-Target-Disease Relationships in PubMed.Journal of chemical information and modeling · 2018Article
- The price of progress: Funding and financing Alzheimer's disease drug development.Alzheimer's & dementia (New York, N. Y.) · 2018Article
- Ideation and implementation of an open science drug discovery business model - M4K Pharma.Wellcome open research · 2018Article
- Data Mining and Computational Modeling of High-Throughput Screening Datasets.Methods in molecular biology (Clifton, N.J.) · 2018Article
- Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology.Cancer cell · 2017Review
- Institutional profile: the national Swedish academic drug discovery & development platform at SciLifeLab.Future science OA · 2017Article
- Changing R&D models in research-based pharmaceutical companies.Journal of translational medicine · 2016Review
- Consortia's critical role in developing medical countermeasures for re-emerging viral infections: a USA perspective.Future virology · 2016Article
- Academic-Industrial Collaboration: Toward the Consilience of Two Solitudes.ACS medicinal chemistry letters · 2016Article
- The European Lead Factory: A Blueprint for Public-Private Partnerships in Early Drug Discovery.Frontiers in medicine · 2016Review
- Academic drug discovery within the United Kingdom: a reassessment.Nature reviews. Drug discovery · 2015Article
- Mitigating risk in academic preclinical drug discovery.Nature reviews. Drug discovery · 2015Review
- A brief review of recent Charcot-Marie-Tooth research and priorities.F1000Research · 2015Review
- Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?Immunological reviews · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.